NOK 14.0
(-6.35%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 11.56 Million NOK | 193.82% |
2022 | -12.32 Million NOK | 25.32% |
2021 | -16.5 Million NOK | -195.94% |
2020 | -5.57 Million NOK | 13.42% |
2019 | -6.44 Million NOK | 24.5% |
2018 | -8.53 Million NOK | -802.71% |
2017 | -944.96 Thousand NOK | -27.93% |
2016 | -738.65 Thousand NOK | 0.0% |
2015 | - NOK | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 6.43 Million NOK | 1466.83% |
2024 Q1 | 410.95 Thousand NOK | -92.02% |
2023 Q3 | 2.56 Million NOK | 108.83% |
2023 Q1 | 2.61 Million NOK | -50.79% |
2023 Q4 | 5.15 Million NOK | 100.67% |
2023 FY | 11.56 Million NOK | 193.82% |
2023 Q2 | 1.22 Million NOK | -52.91% |
2022 Q4 | 5.3 Million NOK | -21.37% |
2022 Q2 | - NOK | 0.0% |
2022 FY | -12.32 Million NOK | 25.32% |
2022 Q3 | 6.74 Million NOK | 0.0% |
2021 FY | -16.5 Million NOK | -195.94% |
2020 FY | -5.57 Million NOK | 13.42% |
2019 FY | -6.44 Million NOK | 24.5% |
2018 FY | -8.53 Million NOK | -802.71% |
2017 FY | -944.96 Thousand NOK | -27.93% |
2016 FY | -738.65 Thousand NOK | 0.0% |
2015 FY | - NOK | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Gentian Diagnostics ASA | 69.44 Million NOK | 83.353% |
Medistim ASA | 222.57 Million NOK | 94.806% |